DaVita Inc. (DVA) key performance indicators and operating metrics (19 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Consolidated revenues | 3.42B | FY2026-Q1 |
| Free cash flow (Free Cash Flow) | 140M | FY2026-Q1 |
| Normalized non-acquired treatment growth (YoY) | 0.10 percent | FY2026-Q1 |
| Other revenues | 142.75M | FY2026-Q1 |
| Adjusted operating income (non-GAAP) | 586M | FY2025-Q4 |
| Outpatient dialysis centers (total) | 3.24K | FY2025-Q4 |
| Total patients | 295K | FY2025-Q4 |
| Annualized medical spend (risk-based IKC) | 5.6B | FY2025-Q4 |
| IKC risk-based integrated care patients | 66K | FY2025-Q4 |
| Total U.S. dialysis treatments (Volume) | 7.26M | FY2025-Q4 |
| Other integrated care patients | 9.4K | FY2025-Q4 |
| Total U.S. dialysis treatments | 7.24M | FY2025-Q3 |
| Average treatments per day | 91.68K | FY2025-Q3 |
| Adjusted diluted EPS (non-GAAP) | 2.51 USD_per_share | FY2025-Q3 |
Back to DVA overview · DVA earnings · DVA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.